R

Ryvu Therapeutics

Biotechnology · Poland · 500 employees

Biotechnology Poland B2B Est. 2007
27 Decision makers
+1 New (6 months)
500 Employees
$19M Revenue
2007 Founded

Organizational Chart of Ryvu Therapeutics

Roles identified within Ryvu Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Ryvu Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Ryvu Therapeutics by function

General management

Human resources

Other functions

See all Ryvu Therapeutics contacts on Zeliq

Decision makers at Ryvu Therapeutics

27 identified 7 C-Level 20 Directors +1 new (6 months)
See them on Zeliq →

Departments actively hiring 1 department

General management

These departments at Ryvu Therapeutics are actively recruiting: a strong signal to time your outreach.

Funding and news at Ryvu Therapeutics

Funding

Last round Other
Total funding $72M (7 rounds)
Post-IPO Equity N/A Aug 2017
Grant $6M Jun 2020
Post-IPO Debt $22M Aug 2022
Post-IPO Equity $21M Nov 2022
Grant $14M Sep 2023
Post-IPO Debt $9M Mar 2024
Post-IPO Debt N/A Aug 2024

Latest news at Ryvu Therapeutics

  1. Appointment

    New Delivery Director appointed — Operations

Get these new hires' email and phone →

Team Structure headcount by department

Research
82
Other
24
Medical
19
Project Management
15
Hiring General Management
11
Operations
9
Technical
9
HR
7

How to prospect Ryvu Therapeutics's departments

Research

This is where the company's largest headcount sits (82 people). Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Other

The company's second-largest department (24 people). A cross-functional team where use cases vary: qualify the actual roles before tailoring your pitch.

Medical

This department counts 19 people. Time with patients is the priority: position your solution as a way to give hours back to care.

Project Management

15 people work in this department. Deadlines and cross-team coordination are the daily battle: position yourself on predictability and visibility.

General Management

A team of 11 people, currently hiring. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Operations

A team of 9 people. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

Try the Zeliq email finder demo →

FAQ Ryvu Therapeutics

Who runs Ryvu Therapeutics?

The highest-ranking leadership role identified at Ryvu Therapeutics is “CEO”, based on public data updated 25 Oct 2026.

How many decision makers does Ryvu Therapeutics have?

27 decision makers identified, including 7 at executive level.

How do I contact a decision maker at Ryvu Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Ryvu Therapeutics?

General management, based on published job offers as of 25 Oct 2026.

Companies similar to Ryvu Therapeutics

About Ryvu Therapeutics

Ryvu Therapeutics operates in the Biotechnology industry, based in Poland. The company was founded in 2007 and has a workforce of roughly 500 people. As part of the broader Hospitals and Health Care sector, Ryvu Therapeutics operates specifically in the Biotechnology segment. Its customer base is mainly professional: Ryvu Therapeutics operates on a B2B model. Ryvu Therapeutics has raised funding across 7 rounds totalling $72M. Annual revenue is estimated at around $19M. This profile compiles key information about Ryvu Therapeutics, including industry, size, location, business signals, and B2B contacts, to help sales teams qualify the account and identify the right decision makers before reaching out.

Activity & Market

Ryvu Therapeutics operates in the Biotechnology segment, part of the broader Hospitals and Health Care sector. As a B2B company, Ryvu Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Public company”.